Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Lidocaine gel 1% Recalled by Hiers Enterprises, LLC dba Northwest Compounding Pharmacy Due to Lack of sterility assurance.
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Hiers Enterprises, LLC dba Northwest Compounding Pharmacy directly.
Affected Products
Lidocaine gel 1%, RX, plastic dropper
Quantity: N/A
Why Was This Recalled?
Lack of sterility assurance.
Where Was This Sold?
Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients. These are compounded products - labels vary for each compound - specific to each patient. Firm did not provide labeling.
About Hiers Enterprises, LLC dba Northwest Compounding Pharmacy
Hiers Enterprises, LLC dba Northwest Compounding Pharmacy has 17 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report